DETECTION OF TOXOPLASMA-GONDII IN VENOUS-BLOOD FROM AIDS PATIENTS BY POLYMERASE CHAIN-REACTION

被引:82
作者
DUPOUYCAMET, J
DESOUZA, SL
MASLO, C
PAUGAM, A
SAIMOT, AG
BENAROUS, R
TOURTESCHAEFER, C
DEROUIN, F
机构
[1] HOP ST LOUIS,PARASITOL MYCOL LAB,F-75011 PARIS,FRANCE
[2] INSERM,U332,INST COCHIN GENET MOLEC,F-75014 PARIS,FRANCE
[3] HOP BICHAT,SERV MALAD INFECT,F-75877 PARIS 18,FRANCE
关键词
D O I
10.1128/JCM.31.7.1866-1869.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Detection of Toxoplasma gondii in blood by means of the polymerase chain reaction (PCR) may facilitate the diagnosis and follow-up of cerebral toxoplasmosis in patients with AIDS. We evaluated this approach with seven patients with tissue culture-proven parasitemia, 14 patients with presumptive cerebral toxoplasmosis, and 17 healthy human immunodeficiency virus-positive controls. Each sample of blood was assayed on three different occasions by a PCR assay based on detection of the gene encoding the P30 surface protein. A positive PCR diagnosis required positivity in at least two of the three PCR tests. None of the controls had a positive PCR diagnosis, but six of the seven patients with parasitemia did. Cerebral toxoplasmosis was confirmed in 13 of the 14 patients with a presumptive diagnosis; diagnosis by PCR was positive before treatment for 9 of these 13 patients, whereas tissue culture was positive for only 1 patient. During treatment, blood samples were taken from 14 patients at regular intervals until day 12. PCR diagnosis became negative on ethidium-stained gels, but persistent signals were observed after hybridization, in some cases, for up to 12 days after initiation of therapy. PCR on venous blood could thus be a sensitive and noninvasive method for the diagnosis of cerebral and disseminated toxoplasmosis in AIDS patients and could be a potential tool for monitoring the effects of treatment.
引用
收藏
页码:1866 / 1869
页数:4
相关论文
共 28 条
[1]  
BOUGNOUX ME, 1990, PRESSE MED, V19, P1751
[2]  
BREZIN AP, 1991, NEW ENGL J MED, V324, P699
[3]  
BURG JL, 1988, J IMMUNOL, V141, P3584
[4]   CONTRIBUTION OF A NEW PCR ASSAY TO THE PRENATAL-DIAGNOSIS OF CONGENITAL TOXOPLASMOSIS [J].
CAZENAVE, J ;
FORESTIER, F ;
BESSIERES, MH ;
BROUSSIN, B ;
BEGUERET, J .
PRENATAL DIAGNOSIS, 1992, 12 (02) :119-127
[5]  
CRISTINA N, 1992, PATHOL BIOL, V40, P52
[6]   TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS - A RANDOMIZED TRIAL COMPARING PYRIMETHAMINE PLUS CLINDAMYCIN TO PYRIMETHAMINE PLUS SULFADIAZINE [J].
DANNEMANN, B ;
MCCUTCHAN, JA ;
ISRAELSKI, D ;
ANTONISKIS, D ;
LEPORT, C ;
LUFT, B ;
NUSSBAUM, J ;
CLUMECK, N ;
MORLAT, P ;
CHIU, J ;
VILDE, JL ;
ORELLANA, M ;
FEIGAL, D ;
BARTOK, A ;
HESELTINE, P ;
LEEDOM, J ;
REMINGTON, J .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) :33-43
[7]  
DEROUIN F, 1992, PRESSE MED, V21, P1853
[8]  
DEROUIN F, 1991, PATHOL BIOL, V39, P255
[9]   LABORATORY DIAGNOSIS OF PULMONARY TOXOPLASMOSIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
DEROUIN, F ;
SARFATI, C ;
BEAUVAIS, B ;
ILIOU, MC ;
DEHEN, L ;
LARIVIERE, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (07) :1661-1663
[10]   COMPARATIVE-STUDY OF TISSUE-CULTURE AND MOUSE INOCULATION METHODS FOR DEMONSTRATION OF TOXOPLASMA-GONDII [J].
DEROUIN, F ;
MAZERON, MC ;
GARIN, YJF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1597-1600